Urolithiasis Management Devices Market - Forecast(2021 - 2026)

Report Code: HCR 0676 Report Format: PDF + Excel (Delivery in 48 Hrs)

Urolithiasis Management Devices Market Overview

Urolithiasis Management Devices Market size was valued at $1.4 billion in 2020, and is expected to grow with a CAGR of 4.3% during the forecast period 2021-2026. Urolithiasis refers to the development of stones in the urinary system and is classified based on the location of stone formation. Nephrolithiasis is the development of kidney stones and is one of the most common chronic disorders and is currently a major health concern. According to the European Association of Urology, around 10% of the world's population is affected by Urolithiasis. Also, the recurrence rate of this nephrolithiasis disorder is approximately 50% in a patient’s lifetime. Moreover, rising prevalence and incidence rates of urolithiasis Management device coupled with increasing preference for minimally invasive surgeries around the globe are some of the key factors contributing for urolithiasis Management devices market and its procedures during the aforesaid period.

Urolithiasis Management Devices Market Report Coverage

The report: “Urolithiasis Management Devices Market – Forecast (2021-2026)”, by IndustryARC, covers an in-depth analysis of the following segments of the Urolithiasis Management Devices Market.

By Product: Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Other Treatments.
By End Users: Hospitals, Clinics, Ambulatory Surgical Centers.
By Geography: North America (U.S., Canada, Mexico), Europe (Germany, U.K., France, Italy, Spain, Russia and Others), Asia Pacific (China, Japan, India, South Korea, Australia & New Zealand and Others), South America (Brazil, Argentina and others), and Rest of the World (Middle East and Africa).

Key Takeaways

  • In 2020, North America dominated the Urolithiasis Management Devices Market owing to the increasing prevalence of kidney stones, rising geriatric population, and campaigns to raise awareness of the risks associated with kidney stones by government agencies among patients in the region.
  • Increasing prevalence of kidney stones, nephrolithiasis and Urolithiasis surgeries among patients across the globe is driving the market growth of Urolithiasis Management Devices.
  • Detailed analysis of the Strength, Weakness, and opportunities of the prominent players operating in the market will be provided in the Urolithiasis Management Devices Market report.

Urolithiasis Management Devices Market Segment Analysis – By Product

Based on the Product, Urolithiasis Management Devices Market is segmented into Extracorporeal Shock Wave Lithotripsy (Eswl), Intracorporeal Lithotripsy, Other Treatments. The Extracorporeal Shock Wave Lithotripsy (Eswl) segment is estimated to dominate the market during the period 2021-2026. This is owing to the Extracorporeal Shock Wave Lithotripsy treatment is usually provided by healthcare providers and is cost-effective. It is usually an outpatient treatment as there is no need for the hospital stay and works well in the case of relatively small urinary stones that are common in patients with stones. The Intracorporeal Lithotripsy segment is forecast to be the fastest-growing segment and is projected to grow at a CAGR of 4.9% during the period 2021-2026. This is Mainly owing to Intracorporal Lithotripsy, which produces an impressive freestone result, and although an invasive procedure requires a short time with no specific adverse effects compared to ESWL. Lithotripsy is a technique for the treatment of kidney and ureter stones that do not require surgery.

Urolithiasis Management Devices Market Segment Analysis – By End Users

Based on the End Users, Urolithiasis Management Devices Market is segmented into Hospitals, Clinics, Ambulatory Surgical Centres. In 2020, Hospitals segment held major share in the Urolithiasis Management Devices Market. This is owing to the investments made by hospitals in the expansion of surgical infrastructures, the increasing number of kidney stone procedures performed in hospitals, and the establishment of new hospitals in different geographies. Also, Ambulatory Surgical Centres are projected to grow with a CAGR of 5.3% over the period 2021-2026. This is owing to ambulatory surgical centres offers time-saving and cost-effective treatment options for nephrolithiasis, cystolithiasis, Extracorporeal Shock Wave Lithotripsy among other kidney stones, and offer time-saving and cost-effective treatment options to reduce prolonged hospital stay.

Urolithiasis Management Devices Market Segment Analysis – By Geography

North America dominated the Urolithiasis Management Devices Market share accounting for 38.1% of the market in 2020. This is owing to the rising introduction of new and innovative urolithiasis management devices, such as laser lithotripters for nephrolithiasis and flexible ureteroscopes, which have also contributed to the healthy growth of the North American market for urolithiasis management devices. However, the Asia-Pacific region is projected to be the fastest-growing over the period 2021-2026. Owing to the rising health care spending by emerging economies such as India and China for Urolithiasis Management Devices and an increasing number of kidney stone cases in the region.

Urolithiasis Management Devices Market Drivers

Increasing prevalence of urinary stones and its higher recurrence rate

Globally, kidney stone disease prevalence and recurrence rates are increasing owing to the prevalence of urolithiasis has increased in both developed and developing countries over the last decades. This growing trend is believed to be associated with lifestyle changes such as lack of physical activity and dietary habits and global warming. In the United States, kidney stone affects 1 in 11 people and it is estimated that 600,000 Americans suffer from urinary stone. this is led to drive the growth of Urolithiasis Management Devices Market.

Growing adoption of minimally invasive stone removal procedure

High adoption of minimally invasive techniques in general and its minimal side effects compared to open surgical procedures for nephrolithiasis cystolithiasis, Extracorporeal Shock Wave Lithotripsy, Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and are likely to drive the demand for an advanced procedure for Urolithiasis Management Devices in the future. According to the journal of advances in chronic kidney diseases, minimally invasive treatments that have been adopted for mainly kidney stone diseases like nephrolithiasis, Extracorporeal Shock Wave Lithotripsy, Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy. Moreover, surgeons are using minimally invasive conduct that was earlier performed as open surgery. The Growing adoption of minimally invasive stone removal procedure dynamics is driving demand for Urolithiasis Management Devices Market.

Urolithiasis Management Devices Market Challenges

The Covid-19 pandemic made an adverse impact on the Urolithiasis Management Devices Market resulting drop in revenue of the market. Many small hospitals and nursing homes were forced to temporarily closed their operation because of the lockdown Moreover, limited availability of Urolithiasis devices, Sluggish medical device manufacturing rate and shutdown in economy are some are major challenges faced by the Urolithiasis Management Devices Market.

Urolithiasis Management Devices Market Landscape

Product launches, Merger & Acquisitions, joint ventures and R&D activities are key strategies adopted by players in the Urolithiasis Management Devices Market. Urolithiasis Management Devices top 10 companies are Allengers Medical Systems Ltd, Boston Scientific Corporation, C.R. Bard Inc, Cook Medical, ConMed Corporation, DirexGroup, Dornier MedTech GmbH, Karl Storz GmbH & Co. KG, Guangzhou Potent Optotronic Technology Co., Ltd, HealthTronics, Inc among others.

Developments

  • In March 2019, Dornier MedTech Announces Dornier OptiVision Next Generation Digital Image Processing Technology for Urolithiasis Stone Treatment and Day-to-Day Endourology.
  • In March 2019, HealthTronics and NextMed, two mobile health care providers, have agreed to merge, and the U.S. Federal Trade Commission is investigating the potential competitive impact of the deal with a focus on company urology treatment devices.

Relevant Reports:

Extracorporeal Shock Wave Lithotripsy Market
HCR 0173

Lithotripsy Devices Market
HCR 72783

For more Lifesciences and Healthcare Market reports, please click here

1. Urolithiasis Management Devices Market Overview
    1.1 Definitions and Scope
2. Urolithiasis Management Devices Market Executive Summary
    2.1 Market Revenue, Market Size and Key Trends
    2.2 Key trends by Product Type
    2.3 Key trends By Application Type
    2.4 Key trends By Geography
3. Urolithiasis Management Devices Market Landscape
    3.1 Market Share Analysis- Key Companies
    3.2 Product Benchmarking- Key Companies
    3.3 Financial Analysis - Key Companies
    3.4 Patent Analysis
    3.5 Pricing Analysis
4. Urolithiasis Management Devices Market - Startup companies Scenario Premium Premium
    4.1 Key startup company Analysis by
        4.1.1 Investment
        4.1.2 Revenue
        4.1.3 Venture Capital and Funding Scenario
5. Urolithiasis Management Devices Market - Industry Market Entry Scenario Premium Premium
    5.1 Regulatory Framework Overview
    5.2 New Business and Ease of Doing business index
    5.3 Case Studies of successful ventures
6. Urolithiasis Management Devices Market Forces
    6.1 Market Drivers
    6.2 Market Constraints and Challenges
    6.3 Porters Five Force Model
        6.3.1 Bargaining Power of Suppliers
        6.3.2 Bargaining Powers of Customers
        6.3.3 Threat of New Entrants
        6.3.4 Rivalry Among Existing Players
        6.3.5 Threat of Substitutes
7. Urolithiasis Management Devices Market Strategic Analysis
    7.1 Value Chain Analysis
    7.2 Opportunities Analysis
    7.3 Market Life Cycle
8. Urolithiasis Management Devices Market – By Product Type (Market Size -$Million/$Billion)
    8.1 Extracorporeal Shock Wave Lithotripsy (Eswl)
    8.2 Intracorporeal Lithotripsy
    8.3 Other Treatments
9. Urolithiasis Management Devices Market – By End User Type (Market Size -$Million/$Billion)
    9.1 Hospitals
    9.2 Clinics
    9.3 Ambulatory Surgical Centers
10. Urolithiasis Management Devices Market - By Geography (Market Size -$Million/$Billion)
    10.1 North America
        10.1.1 U.S
        10.1.2 Canada
        10.1.3 Mexico
    10.2 Europe
        10.2.1 U. K
        10.2.2 Germany
        10.2.3 France
        10.2.5 Spain
        10.2.6 Italy
        10.2.7 Russia
        10.2.8 Rest of Europe
    10.3 Asia Pacific
        10.3.1 India
        10.3.2 China
        10.3.3 Japan
        10.3.4 Australia and New Zealand
        10.3.5South Korea
        10.3.6 Rest of Asia pacific
    10.4 South America
        10.4.1 Brazil
        10.4.2 Argentina
        10.4.3 Rest of South America
    10.5 Rest of the World
        10.5.1 Middle East
        10.5.2 Africa
11. Urolithiasis Management Devices Market Entropy
12. Urolithiasis Management Devices Market - Industry / Segment Competition landscape Premium Premium
    12.1 Market Share Analysis
        12.1.1 Market Share by Country- Key companies
        12.1.2 Market Share by Region- Key companies
        12.1.3 Market Share at Global Level- Key companies
        12.1.4 Best Practices for Companies
13. Urolithiasis Management Devices Market - Key Company List by Country Premium Premium
14. Urolithiasis Management Devices Market Company Analysis (Company Revenue, Products, M&A, Developments)
    14.1 Allengers Medical Systems Ltd.
    14.2 Boston Scientific Corporation
    14.3 C.R. Bard, Inc.
    14.4 Cook Medical
    14.5 ConMed Corporation
    14.6 DirexGroup
    14.7 Dornier MedTech GmbH
    14.8 Karl Storz GmbH & Co. KG
    14.9 Guangzhou Potent Optotronic Technology Co., Ltd.
    14.10 HealthTronics, Inc.
 "*Financials for private companies would be provided on a best efforts basis”.